Volume 240, Issue 8

Search all Psychopharmacology articles

August 2023

15 articles in this issue

Effects of the dopamine depleting agent tetrabenazine in tests evaluating different components of depressive-like behavior in mice: sex-dependent response to antidepressant drugs with SERT and DAT blocker profiles
Carla Carratalá-Ros
Andrea Martínez-Verdú
Mercè Correa
Original Investigation Open access 05 July 2023 Pages: 1615 - 1628
Assessing attention and impulsivity in the variable stimulus duration and variable intertrial interval rodent continuous performance test schedules using noradrenaline receptor antagonists in female C57BL/6JRj mice
L. Klem
M. M. Nielsen
J. T. Andreasen
Original Investigation Open access 17 June 2023 Pages: 1629 - 1650
Assessing attention and impulsivity in the variable stimulus duration and variable intertrial interval rodent continuous performance test schedules using dopamine receptor antagonists in female C57BL/6JRj mice
L. Klem
M. M. Nielsen
J. T. Andreasen
Original Investigation Open access 28 June 2023 Pages: 1651 - 1666
Clozapine but not lithium reverses aberrant tyrosine uptake in patients with bipolar disorder
R Tabrisi
MD Harun-Rashid
M Msghina
Original Investigation Open access 15 June 2023 Pages: 1667 - 1676
Effects of environmental and pharmacological manipulations on cocaine-vs-negative reinforcer choice in male and female rats
Madison M. Marcus
Matthew L. Banks
Original Investigation 20 June 2023 Pages: 1677 - 1689
Sestrin-2 and hypoxia-ınducible factor-1 alpha levels in major depressive disorder and its subtypes
Esra Aslan
Bahadır Demir
Abdurrahman Altındağ
Original Investigation 13 June 2023 Pages: 1691 - 1704
The effects of hydrocortisone and yohimbine on human behavior in approach-avoidance conflicts
Kim Fricke
Nina Alexander
Susanne Vogel
Original Investigation Open access 14 June 2023 Pages: 1705 - 1717
Effect of lithium administration on brain activity under an emotion regulation paradigm in healthy participants: a functional magnetic resonance imaging study
Pilar Artiach Hortelano
Marieke A. G. Martens
Catherine J Harmer
Original Investigation Open access 20 June 2023 Pages: 1719 - 1734
Clinical outcome data of anxiety patients treated with cannabis-based medicinal products in the United Kingdom: a cohort study from the UK Medical Cannabis Registry
Raphael Rifkin-Zybutz
Simon Erridge
Mikael H Sodergren
Original Investigation Open access 14 June 2023 Pages: 1735 - 1745
Effects of the atypical antipsychotic and D3/D2 dopamine partial agonist cariprazine on effort-based choice behavior: implications for modeling avolition
Alev Ecevitoglu
Gayle A. Edelstein
John D. Salamone
Original Investigation 26 June 2023 Pages: 1747 - 1757
Hippocampal proteins discovery of Panax quinquefolius and Acorus gramineus ameliorating cognitive impairment in diabetic rats
Shuai Huan
Yang Yang
Yujia Zheng
Original Investigation 12 June 2023 Pages: 1759 - 1773
Isoalantolactone relieves depression-like behaviors in mice after chronic social defeat stress via the gut-brain axis
Siming Wang
Qihan Cai
Zhiyu Ni
Original Investigation Open access 03 July 2023 Pages: 1775 - 1787
Antidepressant effects of novel positive allosteric modulators of Trk-receptor mediated signaling – a potential therapeutic concept?
Nather Madjid
Veronica Lidell
Johan Sandin
Original Investigation Open access 03 July 2023 Pages: 1789 - 1804
Sex differences in neuroendocrine, sympathetic nervous system, and affect responses to acute stress in cannabis users
Eric R. Larson
Alexandra B. Moussa-Tooks
Krista M. Wisner
Original Investigation 27 June 2023 Pages: 1805 - 1821
Correction to: Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review
Nina Schimmers
Joost J. Breeksema
Robert A. Schoevers
Correction 17 June 2023 Pages: 1823 - 1823

Volume 240, Issue 8

Effects of the dopamine depleting agent tetrabenazine in tests evaluating different components of depressive-like behavior in mice: sex-dependent response to antidepressant drugs with SERT and DAT blocker profiles

Assessing attention and impulsivity in the variable stimulus duration and variable intertrial interval rodent continuous performance test schedules using noradrenaline receptor antagonists in female C57BL/6JRj mice

Assessing attention and impulsivity in the variable stimulus duration and variable intertrial interval rodent continuous performance test schedules using dopamine receptor antagonists in female C57BL/6JRj mice

Clozapine but not lithium reverses aberrant tyrosine uptake in patients with bipolar disorder

Effects of environmental and pharmacological manipulations on cocaine-vs-negative reinforcer choice in male and female rats

Sestrin-2 and hypoxia-ınducible factor-1 alpha levels in major depressive disorder and its subtypes

The effects of hydrocortisone and yohimbine on human behavior in approach-avoidance conflicts

Effect of lithium administration on brain activity under an emotion regulation paradigm in healthy participants: a functional magnetic resonance imaging study

Clinical outcome data of anxiety patients treated with cannabis-based medicinal products in the United Kingdom: a cohort study from the UK Medical Cannabis Registry

Effects of the atypical antipsychotic and D3/D2 dopamine partial agonist cariprazine on effort-based choice behavior: implications for modeling avolition

Hippocampal proteins discovery of Panax quinquefolius and Acorus gramineus ameliorating cognitive impairment in diabetic rats

Isoalantolactone relieves depression-like behaviors in mice after chronic social defeat stress via the gut-brain axis

Antidepressant effects of novel positive allosteric modulators of Trk-receptor mediated signaling – a potential therapeutic concept?

Sex differences in neuroendocrine, sympathetic nervous system, and affect responses to acute stress in cannabis users

Correction to: Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review

Navigation